High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 “ISTAHIT” study ...
Wenzel Dennig – COO/CFO – CMTA AG | LinkedIn
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 “ISTAHIT” study ...
Healing OVER TIME
Climate mitigation policies and the potential pathways to conflict: Outlining a research agenda - Gilmore - 2021 - WIREs Climate Change - Wiley Online Library
Remote Sensing | Free Full-Text | Information-Based Georeferencing of an Unmanned Aerial Vehicle by Dual State Kalman Filter with Implicit Measurement Equations
Wenzel Dennig – COO/CFO – CMTA AG | LinkedIn
nlp_smalltalk/lastnames.txt at master · mark-watson/nlp_smalltalk · GitHub
Wenzel Dennig - COO/CFO - CMTA AG | XING
The Two Hundred and Forty-Sixth Commencement of Purdue University Spring 2022
Hear the crash, see the flash”
200+ ", Dennig" profiles | LinkedIn
The Two Hundred and Forty-Sixth Commencement of Purdue University Spring 2022
Wenzel Dennig - COO/CFO - CMTA AG | XING
Obituary information for Charleen Mueller
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients – final analysis of a randomized, multicenter, phase III trial | Haematologica
Wenzel Dennig - COO/CFO - CMTA AG | XING
Minnesota Wild - For Ryan Suter, the NHL All-Star Game is...
